Growth Metrics

Edwards Lifesciences (EW) Construction in Progress (2023 - 2025)

Edwards Lifesciences has reported Construction in Progress over the past 3 years, most recently at $301.2 million for Q4 2025.

  • For Q4 2025, Construction in Progress rose 23.44% year-over-year to $301.2 million; the TTM value through Dec 2025 reached $301.2 million, up 23.44%, while the annual FY2025 figure was $301.2 million, 23.44% up from the prior year.
  • Construction in Progress for Q4 2025 was $301.2 million at Edwards Lifesciences, up from $244.0 million in the prior quarter.
  • Over five years, Construction in Progress peaked at $301.2 million in Q4 2025 and troughed at $244.0 million in Q4 2024.
  • A 3-year average of $279.2 million and a median of $292.5 million in 2023 define the central range for Construction in Progress.
  • Biggest five-year swings in Construction in Progress: fell 16.58% in 2024 and later increased 23.44% in 2025.
  • Year by year, Construction in Progress stood at $292.5 million in 2023, then fell by 16.58% to $244.0 million in 2024, then increased by 23.44% to $301.2 million in 2025.
  • Business Quant data shows Construction in Progress for EW at $301.2 million in Q4 2025, $244.0 million in Q4 2024, and $292.5 million in Q4 2023.